Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 10 of 39

  1. tadalafil

    ADCIRCA Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    G04BE08
  2. tasimelteon

    HETLIOZ Vanda Pharmaceuticals Netherlands B.V.

    ORAL FDA: approved Β· EMA: approved

    N05CH
  3. teduglutide

    REVESTIVE Lacuna Pharma Pty Ltd

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved

    A16AX08
  4. telmisartan

    APO-TELMISARTAN Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    C09DA07
  5. temozolomide

    APO-TEMOZOLOMIDE Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01AX03
  6. tenofovir alafenamide

    VEMLIDY Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    ORAL FDA: approved Β· EMA: approved

    J05AF13
  7. teriflunomide

    APO-TERIFLUNOMIDE Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L04AK02
  8. teriparatide

    RITOSA Lacuna Pharma Pty Ltd

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    H05AA02
  9. tezacaftor

    SYMKEVI Vertex Pharmaceuticals (Australia) Pty.

    EMA: approved

    R07AX31
  10. thiotepa

    TEPADINA Teva Pharma GmbH

    INJECTION FDA: approved Β· EMA: approved

    L01AC01
  11. ticagrelor

    ARX-TICAGRELOR AstraZeneca

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    B01AC24
  12. tigecycline

    TIGECYCLINE ACCORD Amneal Pharma Europe Ltd

    INTRAVENOUS FDA: approved Β· EMA: approved Β· NMPA: clinical trials

    J01AA12
  13. tildrakizumab

    ILUMYA Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    L04AC
  14. tirbanibulin

    KLISYRI S.A.

    TOPICAL FDA: approved Β· EMA: approved

    D06BX03
  15. tislelizumab

    TEVIMBRA BEONE MEDICINES AUS PTY LTD

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01FF09
  16. tobramycin

    PFIZER AUSTRALIA PTY LTD Pfizer Australia Pty Ltd

    OPHTHALMIC FDA: approved Β· EMA: approved Β· TGA: approved

    J01GB01
  17. topotecan

    HYCAMTIN Accord Healthcare Pty.

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01CE01
  18. treprostinil

    TREPROSTINIL SCIPHARM SΓ€RL United Therapeutics Europe Ltd

    INHALATION FDA: approved Β· EMA: approved

    B01AC21
  19. ulipristal acetate

    ELLAONE Teva Pharma GmbH

    ORAL FDA: approved Β· EMA: approved

    G03AD02
  20. vadadustat

    VAFSEO Akebia Europe Limited

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

  21. valoctocogene roxaparvovec

    ROCTAVIAN BioMarin Pharmaceutical Australia Pty Ltd

    EMA: approved

    B02BD15
  22. vamorolone

    AGAMREE CATALYST PHARMACEUTICALS, INC.

    ORAL FDA: approved Β· EMA: approved

    H02AB18
  23. varenicline

    PHARMACOR VARENICLINE Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    N07BA03
  24. vedolizumab

    ENTYVIO Lacuna Pharma Pty Ltd

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.